mhurhangee/ep-ind-claims huggingface dataset:
Toggle fixing for fixing to a panel, having a crosspiece which has a screw hole for screwing in a screw transversely with respect to the crosspiece, and having a strip pivotally connected to the crosspiece for handling the toggle fixing during fixing, which strip is pivotable into a position in which it projects from the crosspiece and into a position longitudinal with respect to the crosspiece and at a side of the crosspiece, characterised by a counter-bearing on the strip, against which the crosspiece is supported in a pushing direction of the strip once the strip has been pivoted into the position longitudinal with respect to the crosspiece at the side of the crosspiece.
A method in a wireless device (102, 102a) for transmitting a preamble sequence to a network node, the method comprising: - configuring a number of preamble sequences into two or more preamble sets, wherein each preamble set is associated with at least one respective uplink transmission condition; - determining a transmission condition of an uplink from the wireless device (102, 102a) to the network node; and - selecting one out of the two or more preamble sets based on the determined transmission condition to be a selected preamble set, and a preamble sequence from the selected preamble set to be a selected preamble sequence; as well as - transmitting the selected preamble sequence on the uplink, the method being characterised in that: at least one of the preamble sequences comprises a concatenation in time of one or more identical short sequences (s[n]), each of the short sequences having a same time duration as an orthogonal frequency-division multiplexing, OFDM, symbol used for carrying data traffic in a radio access network of the wireless device (102, 102a). - configuring a number of preamble sequences into two or more preamble sets, wherein each preamble set is associated with at least one respective uplink transmission condition; - determining a transmission condition of an uplink from the wireless device (102, 102a) to the network node; and - selecting one out of the two or more preamble sets based on the determined transmission condition to be a selected preamble set, and a preamble sequence from the selected preamble set to be a selected preamble sequence; as well as - transmitting the selected preamble sequence on the uplink, the method being characterised in that: at least one of the preamble sequences comprises a concatenation in time of one or more identical short sequences (s[n]), each of the short sequences having a same time duration as an orthogonal frequency-division multiplexing, OFDM, symbol used for carrying data traffic in a radio access network of the wireless device (102, 102a).
A method performed by a client computing system in a communications network, the method comprising: within a Graphical User Interface, displaying a contact list and a conversation container to a user, the contact list including a plurality of contact objects, the conversation container being an active object used to represent a first and a second ongoing conversation by a first and a second conversation object; receiving input from a user through the Graphical User Interface, the input instructing the client computing system to move a first contact object from the plurality of contact objects over the conversation container and drop the first contact object into the conversation container; in response to dropping the first contact object into the conversation container, instructing a server to open a first communication session between the client system and a first device associated with the one of the contact objects, the first communication session being of a first media type; and engaging in communication through the first communication session with the first device; comprising receiving user input, wherein the user input selects the second conversation object in response to the user input, instructing the server to put the first communication session on hold and take a second communication session off of hold, the second communication session being between the client system and a plurality of devices. within a Graphical User Interface, displaying a contact list and a conversation container to a user, the contact list including a plurality of contact objects, the conversation container being an active object used to represent a first and a second ongoing conversation by a first and a second conversation object; receiving input from a user through the Graphical User Interface, the input instructing the client computing system to move a first contact object from the plurality of contact objects over the conversation container and drop the first contact object into the conversation container; in response to dropping the first contact object into the conversation container, instructing a server to open a first communication session between the client system and a first device associated with the one of the contact objects, the first communication session being of a first media type; and engaging in communication through the first communication session with the first device; comprising receiving user input, wherein the user input selects the second conversation object in response to the user input, instructing the server to put the first communication session on hold and take a second communication session off of hold, the second communication session being between the client system and a plurality of devices.
A process for preparing a spray-dried detergent particle, said process for preparing the spray-dried detergent particle comprising the steps of: i) mixing an acid precursor of an anionic surfactant and an alkali metal hydroxide neutralizing agent in an aqueous medium to form a partially neutralized solution, wherein the partially neutralised solution comprises an anionic surfactant salt formed in-situ by the reaction of a portion of acid anionic surfactant precursor with the alkali metal hydroxide neutralizing agent and said anionic surfactant salt forms 10 parts to 98 parts of the total anionic surfactant content by weight of the spray-dried detergent particle; and, ii) contacting the partially neutralized solution with a silicate neutralizing agent, wherein the silicate neutralizing agent is provided in an amount sufficient for neutralizing the remaining part of the acid precursor of an anionic surfactant to form a fully neutralized detergent solution, iii) adding laundry ingredient to the fully neutralized detergent solution to form an aqueous detergent slurry wherein the detergent slurry has a water content ranging from 25 wt.% to 40 wt.%; iv) spray-drying the aqueous detergent slurry to form a spray-dried detergent particle. i) mixing an acid precursor of an anionic surfactant and an alkali metal hydroxide neutralizing agent in an aqueous medium to form a partially neutralized solution, wherein the partially neutralised solution comprises an anionic surfactant salt formed in-situ by the reaction of a portion of acid anionic surfactant precursor with the alkali metal hydroxide neutralizing agent and said anionic surfactant salt forms 10 parts to 98 parts of the total anionic surfactant content by weight of the spray-dried detergent particle; and, ii) contacting the partially neutralized solution with a silicate neutralizing agent, wherein the silicate neutralizing agent is provided in an amount sufficient for neutralizing the remaining part of the acid precursor of an anionic surfactant to form a fully neutralized detergent solution, iii) adding laundry ingredient to the fully neutralized detergent solution to form an aqueous detergent slurry wherein the detergent slurry has a water content ranging from 25 wt.% to 40 wt.%; iv) spray-drying the aqueous detergent slurry to form a spray-dried detergent particle.
Sliding pendulum bearing for protecting a construction against dynamic stresses from predominantly horizontal earthquake excitation, having a first sliding plate, a second sliding plate and a slider movably arranged between both sliding plates, wherein each of the two sliding plates has a curved main sliding surface (10, 20) and the slider is in surface contact with a first main sliding surface of the first sliding plate and with a second main sliding surface of the second sliding plate, wherein the first main sliding surface is designed for a first load case and the second main sliding surface is designed for a second load case which differs from the first load case, wherein the first and the second load cases represent specific peak ground acceleration values of corresponding earthquakes, characterized in that the first main sliding surface has a first effective radius of curvature R eff,1 and the second main sliding surface has a second effective radius of curvature R eff,2, wherein the sum of R eff,1 and R eff,2 is at least 1.4 times the effective radius of curvature that is determined under the assumption that the sliding pendulum bearing has only one single curved main sliding surface. wherein the first main sliding surface is designed for a first load case and the second main sliding surface is designed for a second load case which differs from the first load case, wherein the first and the second load cases represent specific peak ground acceleration values of corresponding earthquakes, characterized in that the first main sliding surface has a first effective radius of curvature R eff,1 and the second main sliding surface has a second effective radius of curvature R eff,2, wherein the sum of R eff,1 and R eff,2 is at least 1.4 times the effective radius of curvature that is determined under the assumption that the sliding pendulum bearing has only one single curved main sliding surface.
Drive unit for a drug delivery device, comprising: - a carrier, - a plunger arranged within the carrier and slidable in a direction of a longitudinal axis, - a drive spring arranged for biasing the plunger in a distal direction relative to the carrier, - a drive force adaption mechanism for modifying a force exerted by the drive spring on the plunger, wherein the carrier is arranged within a case and axially constrained in a proximal direction with respect to the case, characterized in that the drive spring is a compression spring, wherein the drive force adaption mechanism comprises at least one disk-shaped insert arrangeable within the case in a fixed axial position providing a backstop for the carrier or wherein the drive force adaption mechanism comprises at least one resilient beam arranged on the carrier and radially outwardly biased for engaging at least one of a series of axially consecutive notches inside the case, wherein a respective hole through the case is arranged in each notch allowing for disengaging the beam from the notch to alter an initial length of the drive spring and/or wherein the drive force adaption mechanism comprises a case beam on the case adapted to axially overlap the case on the inside, wherein a screw is transversally arranged through the case adapted to contact the case beam and press it radially inwards onto the carrier depending on a tightening of the screw to introduce a friction force opposing a force of the drive spring. - a carrier, - a plunger arranged within the carrier and slidable in a direction of a longitudinal axis, - a drive spring arranged for biasing the plunger in a distal direction relative to the carrier, - a drive force adaption mechanism for modifying a force exerted by the drive spring on the plunger, wherein the carrier is arranged within a case and axially constrained in a proximal direction with respect to the case, characterized in that the drive spring is a compression spring, wherein the drive force adaption mechanism comprises at least one disk-shaped insert arrangeable within the case in a fixed axial position providing a backstop for the carrier or wherein the drive force adaption mechanism comprises at least one resilient beam arranged on the carrier and radially outwardly biased for engaging at least one of a series of axially consecutive notches inside the case, wherein a respective hole through the case is arranged in each notch allowing for disengaging the beam from the notch to alter an initial length of the drive spring and/or wherein the drive force adaption mechanism comprises a case beam on the case adapted to axially overlap the case on the inside, wherein a screw is transversally arranged through the case adapted to contact the case beam and press it radially inwards onto the carrier depending on a tightening of the screw to introduce a friction force opposing a force of the drive spring.
A verification method, comprising: performing Bluetooth authentication with a terminal based on Bluetooth authentication information; after the Bluetooth authentication with the terminal succeeds, obtaining radio frequency identification RFID authentication information, wherein the RFID authentication information comprises label information and authorization information of an RFID label, and the authorization information is used to indicate an association relationship between the RFID label and the terminal; and performing RFID authentication based on the RFID authentication information, and being in a controllable state after the RFID authentication succeeds. performing Bluetooth authentication with a terminal based on Bluetooth authentication information; after the Bluetooth authentication with the terminal succeeds, obtaining radio frequency identification RFID authentication information, wherein the RFID authentication information comprises label information and authorization information of an RFID label, and the authorization information is used to indicate an association relationship between the RFID label and the terminal; and performing RFID authentication based on the RFID authentication information, and being in a controllable state after the RFID authentication succeeds.
A taste-masked microcapsule pharmaceutical composition of a bisquinoline drug, wherein the microcapsule comprises a drug core of a pharmaceutically effective amount of piperaquine tetraphosphate tetrahydrate and a coating over the core of ethylcellulose, and having an average weight of the coating of said microcapsule of from about 5 to about 30 % weight of the total weight of the microcapsule composition.
A method of notifying a diabetes user of certain glycemic condition of the user with an analyte measurement and management device, the method comprising: conducting a glucose measurement before a meal with the analyte measurement and management device; flagging the before meal glucose measurement in a memory of the analyte measurement and management device as a pre-meal glucose value; conducting a glucose measurement after the meal with the analyte measurement and management device; flagging the after-meal glucose measurement in the memory of the analyte measurement and management device as a post-meal value; determining whether a difference between the flagged post-meal glucose value and flagged pre-meal glucose value is within about 50 mg/dL; and notifying the user whenever the difference is greater than about 50 mg/dL and reminding the user to re-test in a second retest time period. conducting a glucose measurement before a meal with the analyte measurement and management device; flagging the before meal glucose measurement in a memory of the analyte measurement and management device as a pre-meal glucose value; conducting a glucose measurement after the meal with the analyte measurement and management device; flagging the after-meal glucose measurement in the memory of the analyte measurement and management device as a post-meal value; determining whether a difference between the flagged post-meal glucose value and flagged pre-meal glucose value is within about 50 mg/dL; and notifying the user whenever the difference is greater than about 50 mg/dL and reminding the user to re-test in a second retest time period.
An IOP control device for implantation in an eye of a patient, comprising: a housing sized for implantation into the eye of the patient and including an entrance port and an exit port; a membrane anchored within the housing in a manner forming a flow control chamber on a first side of the membrane and a fluid flow passageway on a second opposing side of the membrane, the flow control chamber including a flow control chamber pressure and the fluid flow channel including a fluid flow channel pressure, the membrane configured to affect flow through the fluid flow passageway from the entrance port to the exit port by deflecting in response to pressure differentials of the flow control chamber pressure and the fluid flow channel pressure acting on the opposing sides of the membrane; and a position sensor system configured to detect the position of the membrane including: a first conductive portion; and a second conductive portion positioned to selectively contact the first conductive portion to indicate the position of the membrane relative to the fluid flow passageway. a housing sized for implantation into the eye of the patient and including an entrance port and an exit port; a membrane anchored within the housing in a manner forming a flow control chamber on a first side of the membrane and a fluid flow passageway on a second opposing side of the membrane, the flow control chamber including a flow control chamber pressure and the fluid flow channel including a fluid flow channel pressure, the membrane configured to affect flow through the fluid flow passageway from the entrance port to the exit port by deflecting in response to pressure differentials of the flow control chamber pressure and the fluid flow channel pressure acting on the opposing sides of the membrane; and a position sensor system configured to detect the position of the membrane including: a first conductive portion; and a second conductive portion positioned to selectively contact the first conductive portion to indicate the position of the membrane relative to the fluid flow passageway. a first conductive portion; and a second conductive portion positioned to selectively contact the first conductive portion to indicate the position of the membrane relative to the fluid flow passageway.
A method for sterility testing of a liquid pharmaceutical composition comprising: (a) providing a filterable pharmaceutical composition; (b) filtering the pharmaceutical composition to provide at least three filter membranes upon which the pharmaceutical composition filtrand is deposited; (c) placing the at least three filter membranes onto solid culture media to produce at least three filtrand cultures; (d) culturing (i) at least one filtrand culture under aerobic conditions at 20-25°C; (ii) at least one filtrand culture under aerobic conditions at 30-35°C; and (iii) at least one of filtrand culture under anaerobic conditions at 30-35°C; with the proviso that none of the filtrand cultures are cultured for a period of more than about 13 days; and (e) detecting a viable microorganism cell, micro-colony or colony on a membrane, wherein the presence of a viable microorganism cell, micro-colony or colony on the membrane indicates the presence of a viable microorganism in the pharmaceutical composition. (a) providing a filterable pharmaceutical composition; (b) filtering the pharmaceutical composition to provide at least three filter membranes upon which the pharmaceutical composition filtrand is deposited; (c) placing the at least three filter membranes onto solid culture media to produce at least three filtrand cultures; (d) culturing (i) at least one filtrand culture under aerobic conditions at 20-25°C; (ii) at least one filtrand culture under aerobic conditions at 30-35°C; and (iii) at least one of filtrand culture under anaerobic conditions at 30-35°C; with the proviso that none of the filtrand cultures are cultured for a period of more than about 13 days; and (e) detecting a viable microorganism cell, micro-colony or colony on a membrane, wherein the presence of a viable microorganism cell, micro-colony or colony on the membrane indicates the presence of a viable microorganism in the pharmaceutical composition.
mRNA molecule suitable for application in gene therapy and/or genetic vaccination, the mRNA molecule comprising a 5'-untranslated region (5'-UTR) and a 3'-untranslated region (3'-UTR), wherein the mRNA comprises at least two modules, wherein each module is a ribonucleic acid moiety, wherein at least one module is an open reading frame encoding a polypeptide or protein of interest, and wherein at least one module is a further coding ribonucleic acid moiety encoding at least one additional polypeptide or protein element encoded in the same open reading frame as the polypeptide or protein of interest, wherein the at least one additional polypeptide or protein element is an element that extends protein half-life, and wherein the polypeptide or protein element is characterized by at least 80% identity to SEQ ID NO. 1705, and wherein the open reading frame is or comprises a G/C-modified nucleic acid sequence, wherein the number of G and/or C nucleotides is increased as compared to the wild-type sequence. wherein each module is a ribonucleic acid moiety, wherein at least one module is an open reading frame encoding a polypeptide or protein of interest, and wherein at least one module is a further coding ribonucleic acid moiety encoding at least one additional polypeptide or protein element encoded in the same open reading frame as the polypeptide or protein of interest, wherein the at least one additional polypeptide or protein element is an element that extends protein half-life, and wherein the polypeptide or protein element is characterized by at least 80% identity to SEQ ID NO. 1705, and wherein the open reading frame is or comprises a G/C-modified nucleic acid sequence, wherein the number of G and/or C nucleotides is increased as compared to the wild-type sequence.